Nevro Corp (NVRO) concluded trading on Thursday at a closing price of $5.72, with 12.72 million shares of worth about $72.78 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -34.18% during that period and on February 06, 2025 the price saw a gain of about 13.94%. Currently the company’s common shares owned by public are about 37.44M shares, out of which, 35.36M shares are available for trading.
Stock saw a price change of 9.79% in past 5 days and over the past one month there was a price change of 50.53%. Year-to-date (YTD), NVRO shares are showing a performance of 53.76% which decreased to -65.19% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $3.16 but also hit the highest price of $17.75 during that period. The average intraday trading volume for Nevro Corp shares is 580.59K. The stock is currently trading 21.92% above its 20-day simple moving average (SMA20), while that difference is up 32.59% for SMA50 and it goes to -13.97% lower than SMA200.
Nevro Corp (NYSE: NVRO) currently have 37.44M outstanding shares and institutions hold larger chunk of about 98.91% of that.
The stock has a current market capitalization of $214.34M and its 3Y-monthly beta is at 0.98. It has posted earnings per share of -$1.89 in the same period. It has Quick Ratio of 3.76 while making debt-to-equity ratio of 0.90. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for NVRO, volatility over the week remained 7.15% while standing at 7.98% over the month.
Analysts are in expectations that Nevro Corp (NVRO) stock would likely to be making an EPS of -0.76 in the current quarter, while forecast for next quarter EPS is -0.97 and it is -2.37 for next year. For the current quarter EPS, analysts have given the company a lowest target -0.95 which is -0.66 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -0.14 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 4.76% while it is estimated to decrease by -1.14% in next year. EPS is likely to grow at an annualized rate of 5.63% for next 5-years, compared to annual growth of -9.37% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Wells Fargo on December 03, 2024 offering an Equal weight rating for the stock and assigned a target price of $5 to it. Coverage by Morgan Stanley stated Nevro Corp (NVRO) stock as an Underweight in their note to investors on December 02, 2024, suggesting a price target of $4 for the stock. Stock get an Underweight rating from Wells Fargo on August 07, 2024.
